Human mast cells decrease SLPI levels in type II – like alveolar cell model, in vitro

BACKGROUND: Mast cells are known to accumulate at sites of inflammation and upon activation to release their granule content, e.g. histamine, cytokines and proteases. The secretory leukocyte protease inhibitor (SLPI) is produced in the respiratory mucous and plays a role in regulating the activity o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hollander, Camilla, Nyström, Max, Janciauskiene, Sabina, Westin, Ulla
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2003
Assuntos:
Primary Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC194615/
https://ncbi.nlm.nih.gov/pubmed/12952550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-3-14
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares